$AMRZ

Poletti Samuel Jonas purchased $118K of AMRZ

Poletti Samuel Jonas (Chief Strategy & M&A Officer) purchased 2,510 shares of Amrize Ltd (AMRZ) at $46.92 ($0.12M total) on 2026-08-17.

Original reporting
SEC EDGAR · Poletti Samuel Jonas
Published Aug 18, 2026, 4:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 18, 2026, 4:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMRZ
Bullish
low confidence
Mentioned
$AMRZ
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMRZBullishLow
01

Why it matters

The newest fact is the specific open-market purchase size, price, and post-transaction holdings by the company’s Chief Strategy and M&A Officer.

02

Market read

Traders may note the insider buy as a small sentiment input, but there is no accompanying operational or financial update.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, but it still does not provide the insider’s rationale or whether the purchase is part of a broader pattern.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-18, transaction dated 2026-08-17

Background

The article is an SEC Form 4 insider transaction disclosure for Amrize Ltd (AMRZ).

Company-level read

Ticker impact

$AMRZBullishLow confidence
Context

Amrize Ltd insider Poletti Samuel Jonas bought 2,510 shares at $46.9200 on 2026-08-17, totaling $117,769.20.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small unless followed by additional disclosures.

Evidence & confidence

Form 4 insider buys are informational but typically do not change earnings, guidance, or capital structure; the filing provides no new company-specific operational or financial development.

Market effects

No sector-level signal; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider purchases can be routine (tax planning, diversification, or pre-planned behavior) and may not reflect a change in outlook.

Key entities

  • Amrize Ltd

    Subject of the Form 4 insider transaction disclosure.

  • Poletti Samuel Jonas

    Chief Strategy and M&A Officer who purchased shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

High

BofA downgrades Amrize to underperform, cuts price target on slower growth outlook

Bank of America downgraded Amrize to Underperform, cutting its price target to $40 from $50 due to slower earnings growth, market risks, and valuation concerns. The brokerage lowered its 2027-28 adjusted EBITDA and EPS estimates, citing stable U.S. cement prices, Canadian demand pressure from U.S. tariffs, and vulnerable roofing margins. BofA forecasts adjusted EBITDA growth of 3% and adjusted EPS growth of 6% annually over 2026-28, excluding large acquisitions. The bank also trimmed its buildin

$AMRZMed

BofA downgrades Amrize stock on growth concerns, cuts price target to $40

BofA Securities downgraded Amrize Ltd (NYSE:AMRZ) to Underperform, cutting its price target to $40 from $50. The stock is near its 52-week low, down 20% YTD. BofA reduced 2027-28 EBITDA estimates by 3%, citing growth concerns, U.S. cement price stability, and Canada macro risks. Amrize's Q2 earnings missed estimates, though revenue beat forecasts. Other analysts also downgraded the stock due to earnings misses and management changes.

High

Why is Amrize stock sliding today?

Amrize AG (AMRZ) fell 2.9% to CHF 34.13 after JPMorgan downgraded it to Neutral, citing executive departures and missed earnings. The stock hit a 52-week low of CHF 33.64, with JPMorgan lowering its price target to $52 from $57. The broader market showed no significant movement, indicating the decline is company-specific.